These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36845106)

  • 21. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells.
    Huang S; Gilfillan S; Cella M; Miley MJ; Lantz O; Lybarger L; Fremont DH; Hansen TH
    J Biol Chem; 2005 Jun; 280(22):21183-93. PubMed ID: 15802267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translatome analyses by bio-orthogonal non-canonical amino acid labeling reveal that MR1-activated MAIT cells induce an M1 phenotype and antiviral programming in antigen-presenting monocytes.
    Jakob J; Kröger A; Klawonn F; Bruder D; Jänsch L
    Front Immunol; 2023; 14():1091837. PubMed ID: 36875139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
    McWilliam HEG; Mak JYW; Awad W; Zorkau M; Cruz-Gomez S; Lim HJ; Yan Y; Wormald S; Dagley LF; Eckle SBG; Corbett AJ; Liu H; Li S; Reddiex SJJ; Mintern JD; Liu L; McCluskey J; Rossjohn J; Fairlie DP; Villadangos JA
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24974-24985. PubMed ID: 32958637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biased MAIT TCR Usage Poised for Limited Antigen Diversity?
    Souter MNT; Eckle SBG
    Front Immunol; 2020; 11():1845. PubMed ID: 33013835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential antigenic requirements by diverse MR1-restricted T cells.
    Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
    Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights into metabolite antigen recognition by mucosal-associated invariant T cells.
    Awad W; Ciacchi L; McCluskey J; Fairlie DP; Rossjohn J
    Curr Opin Immunol; 2023 Aug; 83():102351. PubMed ID: 37276819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
    Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella Zoster Virus infects mucosal associated Invariant T cells.
    Purohit SK; Corbett AJ; Slobedman B; Abendroth A
    Front Immunol; 2023; 14():1121714. PubMed ID: 37006246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
    Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
    Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
    Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
    Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells.
    Priya R; Brutkiewicz RR
    J Neuroimmunol; 2020 Dec; 349():577428. PubMed ID: 33096293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells.
    Huang S; Gilfillan S; Kim S; Thompson B; Wang X; Sant AJ; Fremont DH; Lantz O; Hansen TH
    J Exp Med; 2008 May; 205(5):1201-11. PubMed ID: 18443227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
    Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
    Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
    Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
    JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.
    Gold MC; McLaren JE; Reistetter JA; Smyk-Pearson S; Ladell K; Swarbrick GM; Yu YY; Hansen TH; Lund O; Nielsen M; Gerritsen B; Kesmir C; Miles JJ; Lewinsohn DA; Price DA; Lewinsohn DM
    J Exp Med; 2014 Jul; 211(8):1601-10. PubMed ID: 25049333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
    Chancellor A; Alan Simmons R; Khanolkar RC; Nosi V; Beshirova A; Berloffa G; Colombo R; Karuppiah V; Pentier JM; Tubb V; Ghadbane H; Suckling RJ; Page K; Crean RM; Vacchini A; De Gregorio C; Schaefer V; Constantin D; Gligoris T; Lloyd A; Hock M; Srikannathasan V; Robinson RA; Besra GS; van der Kamp MW; Mori L; Calogero R; Cole DK; De Libero G; Lepore M
    J Exp Med; 2023 Sep; 220(9):. PubMed ID: 37382893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
    Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
    Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
    McWilliam HEG; Villadangos JA
    Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells.
    Souter MNT; Awad W; Li S; Pediongco TJ; Meehan BS; Meehan LJ; Tian Z; Zhao Z; Wang H; Nelson A; Le Nours J; Khandokar Y; Praveena T; Wubben J; Lin J; Sullivan LC; Lovrecz GO; Mak JYW; Liu L; Kostenko L; Kedzierska K; Corbett AJ; Fairlie DP; Brooks AG; Gherardin NA; Uldrich AP; Chen Z; Rossjohn J; Godfrey DI; McCluskey J; Pellicci DG; Eckle SBG
    J Exp Med; 2022 Sep; 219(9):. PubMed ID: 36018322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR1 presents microbial vitamin B metabolites to MAIT cells.
    Kjer-Nielsen L; Patel O; Corbett AJ; Le Nours J; Meehan B; Liu L; Bhati M; Chen Z; Kostenko L; Reantragoon R; Williamson NA; Purcell AW; Dudek NL; McConville MJ; O'Hair RA; Khairallah GN; Godfrey DI; Fairlie DP; Rossjohn J; McCluskey J
    Nature; 2012 Nov; 491(7426):717-23. PubMed ID: 23051753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.